Vaxxas Company Presentation

1:45 PM–2:00 PM Jun 5, 2019 (US - Eastern)

Theater 3


Vaxxas is pioneering a next-generation vaccine delivery platform that enables robust immune system activation by targeting vaccine components to the abundant immunological cells immediately below the surface of the skin. Vaxxas' proprietary Nanopatch™ technology aims to provide an optimized, differentiated needle-free vaccine delivery solution that safely and cost effectively amplifies vaccine efficacy.

Session ID: 524479